NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study. uri icon

authors

  • Chu, A Y
  • Kao, W H L
  • Coresh, J
  • Arking, D E
  • Pankow, J S
  • Tomaselli, G F
  • Chakravarti, A
  • Wendy Post, MD, MS
  • Spooner, P H
  • Boerwinkle, E

publication date

  • January 1, 2009